A detailed history of Veritas Asset Management LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Veritas Asset Management LLP holds 1,086,479 shares of BIO stock, worth $348 Million. This represents 3.03% of its overall portfolio holdings.

Number of Shares
1,086,479
Previous 1,128,811 3.75%
Holding current value
$348 Million
Previous $308 Million 17.91%
% of portfolio
3.03%
Previous 2.63%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$263.97 - $344.64 $11.2 Million - $14.6 Million
-42,332 Reduced 3.75%
1,086,479 $364 Million
Q2 2024

Aug 12, 2024

SELL
$268.26 - $339.48 $4.91 Million - $6.21 Million
-18,286 Reduced 1.59%
1,128,811 $308 Million
Q1 2024

May 10, 2024

BUY
$304.11 - $351.99 $19.5 Million - $22.6 Million
64,202 Added 5.93%
1,147,097 $397 Million
Q4 2023

Feb 14, 2024

SELL
$269.37 - $365.04 $8.26 Million - $11.2 Million
-30,648 Reduced 2.75%
1,082,895 $350 Million
Q3 2023

Oct 20, 2023

BUY
$350.25 - $422.63 $390 Million - $471 Million
1,113,543 New
1,113,543 $399 Million
Q2 2023

Aug 08, 2023

SELL
$359.49 - $486.4 $4.85 Million - $6.56 Million
-13,489 Reduced 1.17%
1,137,449 $431 Million
Q1 2023

May 10, 2023

SELL
$418.69 - $503.0 $564,812 - $678,547
-1,349 Reduced 0.12%
1,150,938 $551 Million
Q4 2022

Feb 07, 2023

BUY
$351.71 - $456.01 $54.7 Million - $71 Million
155,666 Added 15.62%
1,152,287 $485 Million
Q3 2022

Nov 10, 2022

BUY
$412.59 - $563.26 $94.8 Million - $129 Million
229,859 Added 29.98%
996,621 $416 Million
Q2 2022

Aug 03, 2022

BUY
$463.67 - $597.16 $356 Million - $458 Million
766,762 New
766,762 $380 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Veritas Asset Management LLP Portfolio

Follow Veritas Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritas Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Veritas Asset Management LLP with notifications on news.